Barry Springer
Director/Board Member at IMMUNOPRECISE ANTIBODIES LTD.
Net worth: 11 090 $ as of 30/05/2024
Network origin in Barry Springer first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Biotechnology | 14 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Barry Springer via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
North Dakota State University | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
University of Victoria | College/University | Corporate Officer/Principal Doctorate Degree | |
SOLIGENIX, INC. | Pharmaceuticals: Major | Chairman | |
Fondation Francqui | Director/Board Member | ||
Fund+
Fund+ Investment ManagersFinance Fund+ is an independent Venture Capital firm founded in 2015. The firm is headquartered in Leuven, Belgium. | Investment Managers | Private Equity Investor | |
INVENTIVA | Biotechnology | Director/Board Member | |
Bio-Incubator Leuven
Bio-Incubator Leuven Real Estate DevelopmentFinance Bio-Incubator Leuven is a dynamic and innovative environment that provides lab space and support to R&D-intensive life sciences companies. The private company offers customizable modules that can be modified to meet the specific requirements of each client. The company is based in Leuven, Belgium. Leuven's knowledge institutes, including KU Leuven, University Hospitals Leuven, VIB, and IMEC, generate a huge outflow of knowledge that entails a myriad of innovative ideas for new and existing companies. The CEO of the Belgian company is Michaël de Blauwe. | Real Estate Development | Director/Board Member | |
Intrexon ActoBiotics NV
Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Biotechnology | Director/Board Member | |
Bioxodes SA
Bioxodes SA Pharmaceuticals: MajorHealth Technology Bioxodes SA develops pharmaceutical products. Its programme Ir-CPI, is the first in a novel class of antithrombotics, and is developed for the prevention of thrombosis in a range of applications including cardiopulmonary bypass grafting and percutaneous coronary intervention. The company was founded by Edmond Godfroid and Michel Guyaux on April 20, 2010 and is headquartered in Marche-en-Famenne, Belgium. | Pharmaceuticals: Major | Director/Board Member | |
ORGENESIS INC. | Biotechnology | Director/Board Member | |
Pienter-Jan BV
Pienter-Jan BV Miscellaneous Commercial ServicesCommercial Services Pienter-Jan BV is a Belgian company that provides business and management consulting services. The private company is based in Brasschaat, Belgium. The CEO of the company is Ann Dendoncker. | Miscellaneous Commercial Services | Director/Board Member | |
Life Sciences Research Partners VZW
Life Sciences Research Partners VZW Investment Trusts/Mutual FundsMiscellaneous Life Sciences Research Partners VZW functions as a foundation or endowment. The non-profit company is based in Leuven, Belgium. The Belgian company was founded by Désiré Collen. | Investment Trusts/Mutual Funds | Director/Board Member | |
CoBioRes NV | Director/Board Member | ||
Creabuild NV
Creabuild NV Miscellaneous Commercial ServicesCommercial Services Creabuild NV provides consulting services. The private company is based in Zaventem, Belgium. The Belgian company was founded in 2005. The CEO is Stéphane Vandervelde. | Miscellaneous Commercial Services | Director/Board Member | |
Pinnacle Investments NV | Director/Board Member | ||
Immo David NV
Immo David NV Real Estate DevelopmentFinance Immo David NV engages in the provision real estate rental, sale and purchase services. The company was founded on January 5, 2005 and is headquartered in Asse, Belgium. | Real Estate Development | Director/Board Member | |
Q-Biologicals NV
Q-Biologicals NV BiotechnologyHealth Technology Q-Biologicals NV operates as a bio pharma contract development and manufacturing organization. It provides process development and bio manufacturing services to customers in the biopharmaceutical industry. The company was founded in 2011 and is headquartered in Ghent, Belgium. | Biotechnology | Director/Board Member | |
iTeos Therapeutics SA
iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium. | Pharmaceuticals: Major | Director/Board Member | |
PROMETHERA Biosciences SA
PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Pharmaceuticals: Major | Director/Board Member | |
CELYAD ONCOLOGY SA | Biotechnology | Director/Board Member | |
KEYWARE TECHNOLOGIES NV | Packaged Software | Chief Executive Officer | |
MaSTherCell SA
MaSTherCell SA BiotechnologyHealth Technology MaSTherCell SA engages in providing cell therapy manufacturing services. The company was founded in 2011 and is headquartered in Charleroi, Belgium. | Biotechnology | Director/Board Member | |
Patcobel NV
Patcobel NV Real Estate DevelopmentFinance Patcobel NV provides real estate services. The private company is based in Kortrijk, Belgium. The CEOs are Cindy van Loock and Patrick Lippens. The Belgian company was founded in 1989. | Real Estate Development | Director/Board Member | |
Ogeda SA
Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | Pharmaceuticals: Major | Director/Board Member | |
University of Kansas | College/University | Undergraduate Degree | |
North Carolina State University | College/University | Graduate Degree | |
Concordia College (Minnesota) | College/University | Undergraduate Degree | |
Brandt Holdings Co.
Brandt Holdings Co. Wholesale DistributorsDistribution Services Brandt Holdings Co. operates as a holding company. The firm operates through four divisions: Agriculture, Construction, Real Estate and Entertainment. The Agriculture division offers John Deere branded tractors, parts and related services. The Construction division offers John Deere and Yanmar diesel engines. The Real Estate division projects include urban plains development. The Entertainment Division core attraction is the Fargo Force Hockey Club. The company was founded by Ace A. Brandt in 1992 and is headquartered in Fargo, ND. | Wholesale Distributors | Director of Finance/CFO | |
Immunoprecise Antibodies (Europe) BV
Immunoprecise Antibodies (Europe) BV Pharmaceuticals: MajorHealth Technology Immunoprecise Antibodies (Europe) BV operates as a pharmaceutical company that specializes in antibiotics. Its services include antigen selection, antibody generation, antibody optimization, antibody production, antibody processing and assay development. The company was founded in 2004 and is headquartered in Oss, the Netherlands. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Radboud University Nijmegen | College/University | Doctorate Degree | |
University of Alberta | College/University | Doctorate Degree | |
Concordia College Global Vaccine Institute | College/University | Founder | |
Concordia University | College/University | Corporate Officer/Principal | |
Aldevron LLC
Aldevron LLC BiotechnologyHealth Technology Aldevron LLC engages in the provision of biotechnology services. It offers plasmid DNA, antibodies, and proteins. The company was founded by Michael Chambers and John Ballantyne in 1998 and is headquartered in Fargo, ND. | Biotechnology | Corporate Officer/Principal | |
SMARTPHOTO GROUP NV | Specialty Stores | Comptroller/Controller/Auditor | |
OTTER TAIL CORPORATION | Electric Utilities | Comptroller/Controller/Auditor | |
Anchor Ingredients Co. LLC
Anchor Ingredients Co. LLC Food: Specialty/CandyConsumer Non-Durables Anchor Ingredients Co. LLC engages in the supply of ingredients to the food and pet food industries. It products include grains, seeds, oils, legumes, vegetables, fruits, proteins, nuts, herbs, and snacks. The company was founded by Seth Novak and Al Yablonski in 2015 and is headquartered in Fargo, ND. | Food: Specialty/Candy | Director of Finance/CFO | |
Healthydakota Mutual Holdings | Director/Board Member | ||
Noridian Mutual Insurance Co.
Noridian Mutual Insurance Co. Multi-Line InsuranceFinance Noridian Mutual Insurance Co. is a subsidiary of HealthyDakota Mutual Holdings® that provides solutions for federal, state, and commercial health programs. The non-profit company is based in Fargo, ND, and has subsidiaries in the United States. The company offers claims management, provider network management, contact centers, and medical review services to optimize health plan administration. Noridian has a 300-member clinical staff trusted nationwide and has consistently received top-ranking satisfaction scores above the national average. Daniel Conrad has been the CEO of the company since 2013. | Multi-Line Insurance | Director/Board Member | |
Minnesota State University Moorhead | College/University | Undergraduate Degree | |
TMI Hospitality, Inc.
TMI Hospitality, Inc. Hotels/Resorts/Cruise linesConsumer Services TMI Hospitality, Inc. provides hospitality services. The firm is a developer and management company of select service and extended stay hotels. It represents nationally recognized franchises, including; Marriott, Hilton, Choice Hotels, Carlson, Hyatt, and IHG brands. The company was founded in 1982 and is headquartered in Fargo, ND. | Hotels/Resorts/Cruise lines | Director of Finance/CFO | |
Cellaïon SA
Cellaïon SA BiotechnologyHealth Technology Cellaïon SA is a biotech company located in Mont Saint Guibert, Belgium. Cellaïon aims to restore a favorable environment to reboost the regenerative process of the liver and ensure a second life to the native liver instead of losing it. The Belgian company has a strong IP base issued from their own research and academic research at UCLouvain, developed with the objective to generate new products. Cellaïon's treatment covers the wide spectrum of liver diseases, from the highly life-threatening acute-on-chronic liver-failure (ACLF) and acute alcoholic hepatitis, to intermediate severity acute decompensation of cirrhosis (AD) and progressive chronic liver diseases caused by non-alcoholic steatohepatitis (NASH). The company has built up a series of R&D and collaborative partnerships with both industrial and academic partners, allowing Cellaïon to broaden and accelerate its clinical development. The company was founded by Etienne Marc Sokal, who has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
Louis Jeantet Foundation | Director/Board Member | ||
HYLORIS PHARMACEUTICALS SA | Pharmaceuticals: Major | Director/Board Member | |
EyeD Pharma SA
EyeD Pharma SA Medical SpecialtiesHealth Technology EyeD Pharma SA manufactures and supplies ophthalmology surgical products. Its products include R&D, instrumentation and phaco accessories. The company was founded by Jean-Marie Rakic and Jean-Michel Foidart and is headquartered in Liege, Belgium. | Medical Specialties | Director/Board Member |
Statistics
International
Belgium | 26 |
United States | 18 |
Canada | 4 |
Netherlands | 4 |
France | 2 |
Sectoral
Health Technology | 19 |
Consumer Services | 12 |
Finance | 7 |
Commercial Services | 3 |
Distribution Services | 3 |
Operational
Director/Board Member | 52 |
Corporate Officer/Principal | 17 |
Chief Executive Officer | 14 |
Chairman | 12 |
Director of Finance/CFO | 12 |
Most connected contacts
Insiders | |
---|---|
Chris Buyse | 39 |
James Kuo | 24 |
Gregory Smith | 13 |
Mitchell Levine | 9 |
Lisa Helbling | 9 |
Jennifer Bath | 6 |
Brad McConn | 4 |
Robert Burke | 3 |
Ilse Roodink | 3 |
Kari Graber | 2 |
Barry Duplantis | 2 |
Dirk Witters | 2 |
Frederick Chabot | 1 |
Kristin Taylor | 1 |
- Stock Market
- Insiders
- Barry Springer
- Company connections